Nu Skin announces closure of LifeGen acquisition
Nu Skin announced a month ago that a deal was being worked on to acquire the Wisconsin-based firm along with its proprietary tissue bank and gene expression database, patents and other intellectual property related to anti-aging gene research.
“The global anti-aging market is expected to grow at a rapid rate in the coming years,” said Dr Joseph Chang, Nu Skin's chief scientific officer. “By bringing the proprietary LifeGen scientific assets and expertise in house, we believe we are in a unique position to develop a steady stream of our super-class of anti-aging products."
Nu Skin began its scientific collaboration with the genomics company two years ago with LifeGen's proprietary genetic science supporting its anti-aging products, including the company's most recent introduction of the ageLoc R2 nutritional supplement.
